First Quadrant’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-570
| Closed | -$63K | – | 552 |
|
|
2021
Q1 | $63K | Hold |
570
| – | – | 0.01% | 449 |
|
|
2020
Q4 | $68K | Hold |
570
| – | – | 0.01% | 442 |
|
|
2020
Q3 | $50K | Sell |
570
-939
| -62% | -$82.4K | 0.01% | 490 |
|
|
2020
Q2 | $135K | Sell |
1,509
-367
| -20% | -$32.8K | 0.02% | 480 |
|
|
2020
Q1 | $187K | Buy |
1,876
+1,306
| +229% | +$130K | 0.03% | 389 |
|
|
2019
Q4 | $65K | Hold |
570
| – | – | 0.01% | 504 |
|
|
2019
Q3 | $72K | Hold |
570
| – | – | 0.01% | 508 |
|
|
2019
Q2 | $69K | Hold |
570
| – | – | ﹤0.01% | 609 |
|
|
2019
Q1 | $50K | Sell |
570
-11,666
| -95% | -$1.02M | ﹤0.01% | 639 |
|
|
2018
Q4 | $1.22M | Sell |
12,236
-180,099
| -94% | -$18M | 0.1% | 211 |
|
|
2018
Q3 | $22M | Buy |
192,335
+90,179
| +88% | +$10.3M | 0.49% | 48 |
|
|
2018
Q2 | $9.16M | Buy |
102,156
+92,728
| +984% | +$8.32M | 0.17% | 175 |
|
|
2018
Q1 | $690K | Sell |
9,428
-32
| -0.3% | -$2.34K | 0.01% | 442 |
|
|
2017
Q4 | $549K | Buy |
9,460
+571
| +6% | +$33.1K | 0.01% | 526 |
|
|
2017
Q3 | $399K | Sell |
8,889
-41
| -0.5% | -$1.84K | 0.01% | 594 |
|
|
2017
Q2 | $353K | Sell |
8,930
-2,870
| -24% | -$113K | 0.01% | 598 |
|
|
2017
Q1 | $479K | Hold |
11,800
| – | – | 0.01% | 539 |
|
|
2016
Q4 | $474K | Hold |
11,800
| – | – | 0.01% | 544 |
|
|
2016
Q3 | $427K | Hold |
11,800
| – | – | 0.01% | 561 |
|
|
2016
Q2 | $342K | Buy |
+11,800
| New | +$342K | 0.01% | 533 |
|